Understanding how certain genes affect Rickettsia parkeri infections
Investigating genes of unknown function required for Rickettsia parkeri infection
This study is looking at some new genes in a germ called Rickettsia parkeri that can make people sick, to see how they help the germ infect our cells, which could lead to better treatments for related illnesses.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10892295 on NIH RePORTER |
What this research studies
This research investigates the role of previously unknown genes in the infection process of Rickettsia parkeri, a bacterium that can cause serious diseases. By using advanced techniques like CRISPR and transposon mutagenesis, researchers aim to identify how these genes contribute to the bacterium's ability to infect host cells. The study focuses on understanding the interactions between the bacteria and host cells, which could lead to new therapeutic strategies. Patients may benefit from insights gained about the mechanisms of infection and potential treatments for related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with Rickettsia infections or are at risk of such infections.
Not a fit: Patients with infections caused by other types of bacteria or those not affected by Rickettsia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for infections caused by Rickettsia and similar pathogens.
How similar studies have performed: Other research has shown success in understanding bacterial infections through genetic manipulation, making this approach promising.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Sit, Brandon Yiu Chung — Massachusetts Institute of Technology
- Study coordinator: Sit, Brandon Yiu Chung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.